Company profile

G&G Biotechnology company profile

G&G Biotechnology developing a complete product line of lightweight breast implants for augmentation and reconstruction. The company transforming the breast augmentation and reconstruction industry with B-Lite, the world's first and only lightweight breast implant. Based on its patented B-Lite technology, the company's implants have been designed and rigorously tested for quality and safety. B-Lite enables users to choose larger-volume implants while reducing the risks associated with increased weight. B-Lite's premium offer and the company's unwavering commitment to meaningful innovation, safety and quality give confidence to both surgeons and patients, delivering outstanding satisfaction and sustainable long-term benefits. In 2018, G&G Biotechnology..... For more information, log in to dureach.com to view the full company profile.

Business identity

Operating status
Closed
Company type
For Profit
Founded
2005-01-01

Headquarters

Headquarters
Kinvarra, Connacht, Ireland
Country code
IE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Founders
1
Exited on
2018-07-05

Founders and investors

Founders

Dael Govreen-Segal

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.